|
|
Vaccine Detail
|
0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2021-2022] |
| Vaccine Information |
- Vaccine Name: 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2021-2022]
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Tradename: Flucelvax Quadrivalent 2021-2022
- Vaccine Ontology ID: VO_0019277
- Type: Inactivated or "killed" vaccine
- Host Species for Licensed Use: Human
|
| Host Response |
|
|
| References |
|
|
|
